These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 25060070)
1. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070 [TBL] [Abstract][Full Text] [Related]
2. Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Takahashi H; Ishii H; Nishida N; Takemasa I; Mizushima T; Ikeda M; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M Ann Surg Oncol; 2011 Apr; 18(4):1166-74. PubMed ID: 21125339 [TBL] [Abstract][Full Text] [Related]
3. Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/β-catenin pathway by down-regulating Dickkopf-1 (DKK1) [corrected]. Huang Z; Li S; Song W; Li X; Li Q; Zhang Z; Han Y; Zhang X; Miao S; Du R; Wang L PLoS One; 2013; 8(7):e70077. PubMed ID: 23922913 [TBL] [Abstract][Full Text] [Related]
4. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer. Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067 [TBL] [Abstract][Full Text] [Related]
5. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Lei ZJ; Wang J; Xiao HL; Guo Y; Wang T; Li Q; Liu L; Luo X; Fan LL; Lin L; Mao CY; Wang SN; Wei YL; Lan CH; Jiang J; Yang XJ; Liu PD; Chen DF; Wang B Oncogene; 2015 Jun; 34(24):3188-98. PubMed ID: 25893304 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. Hsu HC; Liu YS; Tseng KC; Hsu CL; Liang Y; Yang TS; Chen JS; Tang RP; Chen SJ; Chen HC Int J Colorectal Dis; 2013 Nov; 28(11):1535-46. PubMed ID: 23784051 [TBL] [Abstract][Full Text] [Related]
8. LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity. Morgan RG; Mortensson E; Legge DN; Gupta B; Collard TJ; Greenhough A; Williams AC Br J Cancer; 2018 Feb; 118(4):558-565. PubMed ID: 29149105 [TBL] [Abstract][Full Text] [Related]
9. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
10. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells. Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387 [TBL] [Abstract][Full Text] [Related]
12. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Fan XS; Wu HY; Yu HP; Zhou Q; Zhang YF; Huang Q Int J Colorectal Dis; 2010 May; 25(5):583-90. PubMed ID: 20195621 [TBL] [Abstract][Full Text] [Related]
13. TSPAN8 promotes colorectal cancer cell growth and migration in LSD1-dependent manner. Zhang HS; Liu HY; Zhou Z; Sun HL; Liu MY Life Sci; 2020 Jan; 241():117114. PubMed ID: 31790687 [TBL] [Abstract][Full Text] [Related]
14. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance. Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111 [TBL] [Abstract][Full Text] [Related]
15. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Xiong B; Cheng Y; Ma L; Zhang C Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819 [TBL] [Abstract][Full Text] [Related]
16. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas. Jang BG; Lee BL; Kim WH Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor. Liao F; Dong W; Fan L Med Oncol; 2010 Dec; 27(4):1219-26. PubMed ID: 19924574 [TBL] [Abstract][Full Text] [Related]
19. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
20. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]